Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Macrogol in Komb. (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD6
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Estradiol, ATC G03CA03
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Ribociclib, ATC L01EF02
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Macrogol (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD15
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Dolutegravir und Rilpivirin, ATC J05AR21
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bimatoprost, ATC S01EE03
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Interferon beta-1a, Fertigarzneimittelbezeichnung Rebif(R), ATC L03AB07
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 3, 2028
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-03
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-08
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2028
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon alfa-2a, ATC L03AB11 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Budesonid (FAM Kinpeygo und austauschbare Arzneimittel), ATC A07EA06 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Abaloparatid, ATC H05AA04 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Darreichungsform PEN und FER), ATC L04AC07 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Naloxegol, ATC A06AH03 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Omalizumab, ATC L04AG08 für die Zeit 01.08.2026 - 31.07.2028
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens
ted.europa.eu
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 5, 2028
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nomegestrol + Estradiol, ATC G03AA14 für die Zeit 01.08.25 - 31.07.27 (zzgl. Verlängerungsoption 1x12 Mon.)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Colchicin, ATC M04AC01 für die Zeit 01.08.2025 - 31.07.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Safinamid, ATC N04BD03 für die Zeit 01.08.2025 - 31.07.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fluorouracil, ATC D11AF05 für die Zeit 01.08.2025 - 31.07.2027 (zzgl. Verlängerungsoption 1x12 Monate)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-06-06
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 6, 2028
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-06-06
TEN
France – Electricity – FOURNITURE ET DISTRIBUTION D'ELECTRICITE
ted.europa.eu
Buyer: COMMUNAUTE DE COMMUNES SUD ROUSSILLON | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2028-06-06
TenderProcurement ContractFranceOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 6, 2028
Buyer: COMMUNAUTE DE COMMUNES SUD ROUSSILLON | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2028-06-06
GRA
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
grants.gov
The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for r...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 7, 2028
The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and other brain and/or body based interventions) impact mechanisms of emotional well-being (EWB) and their associations with whole person health (WPH), consistent with the NIH priority to address the health needs of the American people and improve their well-being. The NOFO will support rigorous and well-powered mechanistic research studies that are supported by strong preliminary data. The studies should examine the effects of mind and body interventions on innovative mechanisms of EWB (as the primary outcome), as well as the associated relationship with the Whole Person Health Index (WPHI, as a secondary outcome). To enhance research safety, rigor, and efficiency of NIH-funded mechanistic cli...
TEN
Lithuania – Laboratory services – KELIŲ ASFALTO SLUOKSNIŲ ĮRENGIMUI NAUDOJAMŲ MEDŽIAGŲ IR GAMINIŲ KONTROLINIŲ LABORATORINIŲ BANDYMŲ PASLAUGOS
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-VerfahrensBuyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2028-06-05
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-06-06
41997
France – Electricity – FOURNITURE ET DISTRIBUTION D'ELECTRICITEBuyer: COMMUNAUTE DE COMMUNES SUD ROUSSILLON | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2...
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Buyer: COMMUNAUTE DE COMMUNES SUD ROUSSILLON | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2028-06-06
41998
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solici...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
The National Center for Complementary and Integrative Health (NCCIH) announces this Notice of Funding Opportunity (NOFO) to solicit applications for research on how mind and body interventions through psychological and/or physical inputs (e.g., mindfulness meditation, yoga, acupuncture, massage, and other brain and/or body based interventions) impact mechanisms of emotional well-being (EWB) and their associations with whole person health (WPH), consistent with the NIH priority to address the health needs of the American people and improve their well-being. The NOFO will support rigorous and well-powered mechanistic research studies that are supported by strong preliminary data. The studies should examine the effects of mind and body interventions on innovative mechanisms of EWB (as the primary outcome), as well as the associated relationship with the Whole Person Health Index (WPHI, as a secondary outcome). To enhance research safety, rigor, and efficiency of NIH-funded mechanistic clinical trials, this initiative will use a two-phased award funding mechanism (R61/R33). The funding will support an initial phase (R61) to establish feasibility benchmarks for the proposed mechanistic clinical trial(s), followed by a second phase (R33) to complete the full-scale trials, which will be contingent upon successful completion of R61 milestones. Applications should provide preliminary data that are comparable in quality and quantity to those expected for an R01 proposal.
41999
Lithuania – Laboratory services – KELIŲ ASFALTO SLUOKSNIŲ ĮRENGIMUI NAUDOJAMŲ MEDŽIAGŲ IR GAMINIŲ KONTROLINIŲ LABORATORINIŲ BANDYMŲ PASLAUGOSBuyer: Akcinė bendrovė "Via Lietuva" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2028-06-0...
Tender
Procurement Contract
Lithuania
Not provided on the source page. Please check the official source.
Slovenia – Food, beverages, tobacco and related products – Nakup in dobava živil z vzpostavitvijo dinamičnega nabavnega sistemaBuyer: CENTER ŠOLSKIH IN OBŠOLSKIH DEJAVNOSTI | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline:...
Tender
Procurement Contract
Slovenia
Not provided on the source page. Please check the official source.
